表紙
市場調查報告書

活細胞封裝的全球市場:各手法 (單純/靜電滴液、同軸氣流、液體噴射)、聚合物的各類型 (海藻酸、幾丁聚醣、二氧化矽、硫酸纖維素)、各用途 (益生菌、細胞移植、藥物輸送、研究)、各地區的未來預測 (到2024年)

Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024

出版商 MarketsandMarkets 商品編碼 819133
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
Back to Top
活細胞封裝的全球市場:各手法 (單純/靜電滴液、同軸氣流、液體噴射)、聚合物的各類型 (海藻酸、幾丁聚醣、二氧化矽、硫酸纖維素)、各用途 (益生菌、細胞移植、藥物輸送、研究)、各地區的未來預測 (到2024年) Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
出版日期: 2019年04月02日內容資訊: 英文 137 Pages
簡介

全球活細胞封裝市場預計2018年為2億5000萬美元,2024年達3億0300萬美元,以3.2%的年複合成長率 (CAGR) 成長。各製造手法中的靜電滴液方式,各聚合物類型中的海藻酸,預計今後大幅成長。還有各用途中藥物輸送部門佔大半的市場佔有率。

本報告提供全球活細胞封裝的市場相關分析,市場基本結構和最新形勢,主要市場促進、阻礙因素,市場趨勢預測 (過去2年、今後6年份),各手法、聚合物的各類型、各用途、各地區的詳細趨勢,市場競爭的狀態,主要企業簡介等調查。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • 標的疾病的發病數量增加
      • 疾病治療用新的藥物輸送
      • 技術進步
      • 公民營雙方的投資擴大,支援新產品開發
      • 在疾病治療中封裝細部臨床上所扮演的角色:社會愈來愈重視
    • 阻礙因素
      • 製造成本高
      • 高品質的原料在市場上取得困難
    • 市場機會
      • 研究活動的活躍
    • 課題
      • 替代性治療方法的引進

第6章 活細胞封裝市場:各製造手法

  • 簡介
  • 單純滴液
  • 靜電滴液
  • 同軸氣流 (coaxial airflow)
  • 液體噴射分裂
  • 噴射震動手法
  • 噴射切割
  • 旋轉盤粒子化

第7章 活細胞封裝市場:聚合物的各類型

  • 簡介
  • 海藻酸
  • HEMA-MMA
  • 幾丁聚醣
  • 二氧化矽封入物
  • 硫酸纖維素
  • PAN-PVC
  • 其他

第8章 活細胞封裝市場:各用途

  • 簡介
  • 藥物輸送
  • 再生醫療
  • 細胞移植
  • 益生菌
  • 研究

第9章 活細胞封裝市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國,法國等)
  • 亞太地區 (日本,中國,印度等)
  • 南美
  • 中東、非洲

第10章 競爭環境

  • 概要
  • 世界市場佔有率分析
  • 競爭方案
  • 企業策略方向性:製圖
    • 企業先驅
    • 創新的企業
    • 活動的企業
    • 新企業

第11章 企業簡介 (產業概要,主要產品,近幾年趨勢,MnM的見解)

  • 簡介
  • BALCHEM CORPORATION
  • BIOTIME, INC.
  • BLACKTRACE GROUP
  • BUCHI LABORTECHNIK AG
  • ENCAPSYS, LLC
  • EVONIK INDUSTRIES
  • LIVING CELL TECHNOLOGIES
  • LYCORED
  • MERCK KGAA
  • MIKROCAPS
  • NEUROTECH HOLDINGS, LLC.
  • REED PACIFIC PTY LIMITED
  • SERNOVA CORPORATION
  • SIGILON THERAPEUTICS
  • VIACYTE, INC.

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 7006

"The live cell encapsulation market is projected to grow at a CAGR of 3.2% during the forecast period"

The global live cell encapsulation market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%. The growth of this market is majorly driven by factors such as the ongoing technological advancements in live cell encapsulation, growing public-private investments in the field of live cell encapsulation, increasing number of target patient population, and the rising awareness related to the clinical role of encapsulated cells in disease management. However, the limited availability of high-quality raw materials, and the significant adoption of alternative therapies are expected to restrain the growth of this market during the forecast period.

"The electrostatic dripping segment to witness the highest growth rate in the live cell encapsulation market, by manufacturing technique"

Based on manufacturing technique, the live cell encapsulation market is segmented into simple dripping, electrostatic dripping, coaxial airflow, liquid-jet break-up, vibrating-jet technique, jet cutting, and rotating disk atomization. The electrostatic dripping segment is expected to account for the high growth rate of this market in 2018, owing to the growing demand for electrostatic dripping as a result of the procedural benefits such as retention of cell viability & potency, and preservation of plant oxidants.

"Alginate segment to witness the highest growth rate in the live cell encapsulation market, by polymer type"

Based on polymer type, the live cell encapsulation market has been segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is estimated to grow at the highest CAGR during the forecast period majorly due to the procedural benefits offered such as the capability to encapsulate living cells with wide pore size distribution (5-200 nm) and high permeability of alginate.

"The drug therapy segment to account for the largest share of the live cell encapsulation market, by application, in 2018"

Based on application, the live cell encapsulation market is segmented into drug delivery, regenerative medicine, cell transplantation, probiotics, and research. The drug delivery segment is expected to account for the largest share of the live cell encapsulation market in 2018. The growth of this application segment can be attributed to the rising incidence of target diseases and increasing research activities on live cell encapsulation in major countries across the globe.

"The North America market to grow at the highest CAGR during the forecast period"

The live cell encapsulation market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The North America market is expected to grow at the highest CAGR during the forecast period majorly due to the increasing research activities in the field of cell encapsulation coupled with the growing public-private investments for cell encapsulation research practices. Furthermore, the increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell encapsulation techniques among medical professionals are the other factors supporting the growth of this market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1-25%, Tier 2-30%, and Tier 3-45%
  • By Designation: C-level-26%, Director-level-30%, and Others-44%
  • By Region: North America-35%, Europe-26%, APAC-23%, and RoW-16%

The major players operating in this market include BioTime, Inc. (US), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (US), Neurotech Pharmaceuticals, Inc. (US), Living Cell Technologies Ltd. (Australia), Merck KGAA (Germany), Sigilon Therapeutics, Inc. (US), Encapsys, LLC (US), Evonik Industries (Germany), Lycored (Israel), MiKroCaps (Slovenia), BUCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), Sernova Corporation (Canada), and Balchem Corporation (US), among others.

Research Coverage

This report studies the live cell encapsulation market based on manufacturing technique, polymer type, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenge) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the live cell encapsulation market, and high-growth regions and their drivers, restraints, opportunities, and challenge. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Major secondary sources referred
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 PROCEDURE-BASED MARKET ESTIMATION
    • 2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 LIVE CELL ENCAPSULATION MARKET OVERVIEW
  • 4.2 EUROPE: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE
  • 4.3 GLOBAL LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE
  • 4.4 LIVE CELL ENCAPSULATION MARKET, BY APPLICATION
  • 4.5 LIVE CELL ENCAPSULATION MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of target diseases
      • 5.2.1.2 Focus on novel drug delivery systems for disease treatment
      • 5.2.1.3 Technology Advancements
      • 5.2.1.4 Increasing public-private investments to support novel product development
      • 5.2.1.5 Rising public awareness related to the clinical role of encapsulated cells in disease management
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High product manufacturing costs
      • 5.2.2.2 Limited market availability of high-quality raw materials
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising research activity
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Adoption of alternative therapies

6 LIVE CELL ENCAPSULATION MARKET, BY MANUFACTURING TECHNIQUES

  • 6.1 INTRODUCTION
  • 6.2 SIMPLE DRIPPING
    • 6.2.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR SIMPLE DRIPPING TECHNIQUE, BY APPLICATION
  • 6.3 ELECTROSTATIC DRIPPING
    • 6.3.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR ELECTROSTATIC DRIPPING TECHNIQUE, BY APPLICATION
  • 6.4 COAXIAL AIRFLOW
    • 6.4.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR COAXIAL AIRFLOW TECHNIQUE, BY APPLICATION
  • 6.5 LIQUID-JET BREAK-UP
    • 6.5.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR LIQUID JET BREAK UP TECHNIQUE, BY APPLICATION
  • 6.6 VIBRATING-JET TECHNIQUE
    • 6.6.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR VIBRATING JET TECHNIQUE, BY APPLICATION
  • 6.7 JET CUTTING
    • 6.7.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR JET CUTTING TECHNIQUE, BY APPLICATION
  • 6.8 ROTATING DISK ATOMIZATION
    • 6.8.1 GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR ROTATING DISK ATOMIZATION TECHNIQUE, BY APPLICATION

7 LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE

  • 7.1 INTRODUCTION
  • 7.2 ALGINATE
    • 7.2.1 ALGINATE IS THE MOST WIDELY ADOPTED MATERIAL FOR THE ENCAPSULATION OF LIVING CELLS
  • 7.3 HEMA-MMA
    • 7.3.1 HEMA-MMA-BASED PRODUCTS ARE USED MAINLY FOR LIVER TRANSPLANTATION PROCEDURES AND DIABETES MANAGEMENT

  • 7.4 CHITOSAN
    • 7.4.1 INADEQUATE AVAILABILITY OF NATURAL CHITOSAN SOURCES IS EXPECTED TO HAMPER MARKET GROWTH
  • 7.5 SILICEOUS ENCAPSULATES
    • 7.5.1 PROCEDURAL BENEFITS SUCH AS EFFECTIVE PROCESS CONTROL & ADJUSTABILITY TO DRIVE MARKET GROWTH
  • 7.6 CELLULOSE SULFATE
    • 7.6.1 TECHNO-COMMERCIAL BENEFITS SUCH AS HIGH MECHANICAL STABILITY & ADJUSTABILITY TO DRIVE MARKET GROWTH
  • 7.7 PAN-PVC
    • 7.7.1 PAN-PVC POLYMERS HAVE MECHANICAL STABILITY, PERMEABILITY, AND HIGH BIOCOMPATIBILITY
  • 7.8 OTHER POLYMERS

8 LIVE CELL ENCAPSULATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DRUG DELIVERY
    • 8.2.1 DRUG DELIVERY FORMS THE LARGEST APPLICATION SEGMENT OF THE LIVE CELL ENCAPSULATION MARKET
  • 8.3 REGENERATIVE MEDICINE
    • 8.3.1 CLINICAL RISK OF HEPATIC CLOGGING SYSTEM IS EXPECTED TO HAMPER THE ADOPTION OF CELL ENCAPSULATION
  • 8.4 CELL TRANSPLANTATION
    • 8.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF CELL TRANSPLANTATION TO SUPPORT MARKET GROWTH
  • 8.5 PROBIOTICS
    • 8.5.1 PROBIOTICS APPLICATIONS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 8.6 RESEARCH
    • 8.6.1 INCREASING AVAILABILITY OF PUBLIC-PRIVATE FUNDING, INVESTMENTS, & GRANTS TO DRIVE MARKET GROWTH

9 LIVE CELL ENCAPSULATION MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US accounted for the largest share due to growing public-private investments for cell encapsulation research
    • 9.2.2 CANADA
      • 9.2.2.1 Growth in the live cell encapsulation market in Canada is driven by the growing research activities related to cell encapsulation
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to witness the highest growth in the European live cell encapsulation market during the forecast period

    • 9.3.2 UK
      • 9.3.2.1 Growth in this market is driven by the technological advancements and efficiency of cell encapsulation techniques
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing prevalence of chronic diseases to drive market growth
    • 9.3.4 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to register the highest growth in the Asia Pacific live cell encapsulation market
    • 9.4.2 CHINA
      • 9.4.2.1 Supportive government regulations for the expansion and modernization of healthcare facilities are driving market growth
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing prevalence of target chronic diseases to support market growth
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GLOBAL MARKET SHARE ANALYSIS (2017)
  • 10.3 COMPETITIVE SCENARIO (2015 TO 2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING
    • 10.4.1 VENDOR INCLUSION CRITERIA
      • 10.4.1.1 Visionary leaders
      • 10.4.1.2 Innovators
      • 10.4.1.3 Dynamic differentiators
      • 10.4.1.4 Emerging companies

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 INTRODUCTION
  • 11.2 BIOTIME, INC.
  • 11.3 BLACKTRACE GROUP
  • 11.4 BUCHI LABORTECHNIK AG
  • 11.5 EVONIK INDUSTRIES
  • 11.6 LIVING CELL TECHNOLOGIES
  • 11.7 NEUROTECH HOLDINGS, LLC.
  • 11.8 SERNOVA CORPORATION
  • 11.9 SIGILON THERAPEUTICS
  • 11.10 VIACYTE, INC.
  • 11.11 PHARMACYTE BIOTECH, INC.
  • 11.12 ALTUCELL, INC.
  • 11.13 BETA-O2 TECHNOLOGIES LTD
  • 11.14 DEFYMED
  • 11.15 GLORIANA THERAPEUTICS
  • 11.16 KADIMASTEM

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 2: LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 4: LIVE CELL ENCAPSULATION MARKET FOR ELECTROSTATIC DRIPPING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: LIVE CELL ENCAPSULATION MARKET FOR ELECTROSTATIC DRIPPING, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 6: LIVE CELL ENCAPSULATION MARKET FOR COAXIAL AIRFLOW, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: LIVE CELL ENCAPSULATION MARKET FOR COAXIAL AIRFLOW, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 8: LIVE CELL ENCAPSULATION MARKET FOR LIQUID-JET BREAK-UP, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: LIVE CELL ENCAPSULATION MARKET FOR LIQUID-JET BREAK-UP, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 10: LIVE CELL ENCAPSULATION MARKET FOR VIBRATING-JET TECHNIQUE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: LIVE CELL ENCAPSULATION MARKET FOR VIBRATING-JET TECHNIQUE, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: LIVE CELL ENCAPSULATION MARKET FOR JET CUTTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: LIVE CELL ENCAPSULATION MARKET FOR JET CUTTING, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 14: LIVE CELL ENCAPSULATION MARKET FOR ROTATING DISK ATOMIZATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: LIVE CELL ENCAPSULATION MARKET FOR ROTATING DISK ATOMIZATION, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 16: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 17: LIVE CELL ENCAPSULATION MARKET FOR ALGINATE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: LIVE CELL ENCAPSULATION MARKET FOR HEMA-MMA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: LIVE CELL ENCAPSULATION MARKET FOR CHITOSAN, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: LIVE CELL ENCAPSULATION MARKET FOR SILICEOUS ENCAPSULATES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: LIVE CELL ENCAPSULATION MARKET FOR CELLULOSE SULFATE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: LIVE CELL ENCAPSULATION MARKET FOR PAN-PVC, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: LIVE CELL ENCAPSULATION MARKET FOR OTHER POLYMERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 25: LIVE CELL ENCAPSULATION MARKET FOR DRUG DELIVERY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: LIVE CELL ENCAPSULATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: LIVE CELL ENCAPSULATION MARKET FOR CELL TRANSPLANTATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: LIVE CELL ENCAPSULATION MARKET FOR PROBIOTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: LIVE CELL ENCAPSULATION MARKET FOR RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: LIVE CELL ENCAPSULATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 37: US: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 38: CANADA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 39: EUROPE: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: EUROPE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 42: EUROPE: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 43: GERMANY: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 44: UK: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 45: FRANCE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 46: ROE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 47: ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 49: ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: JAPAN: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 52: CHINA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 53: INDIA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 54: ROAPAC: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 55: LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 56: LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 58: MEA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 59: MEA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: MEA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 61: KEY PRODUCT LAUNCHES
  • TABLE 62: KEY EXPANSIONS
  • TABLE 63: KEY ACQUISITIONS
  • TABLE 64: KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES: LIVE CELL ENCAPSULATION MARKET
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: MARKET SIZE ESTIMATION: LIVE CELL ENCAPSULATION MARKET
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2018 VS. 2024
  • FIGURE 7: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE, 2018 VS. 2024 (USD MILLION)
  • FIGURE 8: LIVE CELL ENCAPSULATION MARKET SHARE, BY APPLICATION, 2018 VS. 2024
  • FIGURE 9: GEOGRAPHIC SNAPSHOT: LIVE CELL ENCAPSULATION MARKET
  • FIGURE 10: RISING RESEARCH ACTIVITY AND FOCUS ON NOVEL DRUG DELIVERY SYSTEMS FOR DISEASE TREATMENT WILL DRIVE DEMAND FOR LIVE CELL ENCAPSULATION
  • FIGURE 11: ALGINATES TO DOMINATE THE EUROPEAN LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: SIMPLE DRIPPING SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA WILL DOMINATE THE LIVE CELL ENCAPSULATION APPLICATION MARKET IN 2018
  • FIGURE 14: US AND GERMANY TO BE THE FASTEST-GROWING MARKETS FOR LIVE CELL ENCAPSULATION
  • FIGURE 15: LIVE CELL ENCAPSULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: SIMPLE DRIPPING SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: ALGINATE SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: DRUG DELIVERY SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
  • FIGURE 20: EUROPE: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
  • FIGURE 22: LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
  • FIGURE 23: MEA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
  • FIGURE 24: KEY DEVELOPMENTS IN THE LIVE CELL ENCAPSULATION MARKET FROM 2014 TO 2019
  • FIGURE 25: BIOTIME, INC HELD THE LEADING POSITION IN THE LIVE CELL ENCAPSULATION MARKET IN 2017
  • FIGURE 26: COMPETITIVE LEADERSHIP MAPPING (2017)
  • FIGURE 27: BIOTIME, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 28: EVONIK INDUSTRIES: COMPANY SNAPSHOT (2017)
  • FIGURE 29: LIVING CELL TECHNOLOGIES: COMPANY SNAPSHOT (2017)
Back to Top